In case you missed the announcement last fall, ICD-10 codes are going to be updated twice a year beginning in 2022. These updates will be effective on April 1 and October 1 each year going forward. This “In the kNOW” installment will share the rationale for more frequent updates and what to expect this April.
One need only to reflect on the past two years
to get an understanding for the need for more frequent code updates. With the COVID-19 pandemic, coding
professionals saw the unprecedented implementation of a new code to capture
this disease in April of 2020. It is
imperative in such situations to be able to capture this information quickly not
only for coding and billing, but to aid research and track clinical
outcomes.
The initial April updates are planned to be less comprehensive than the October updates. Fewer codes will be implemented in April. The good news is that the April codes that will go into effect are going to be available for review in November of the preceding year. That gives coding professionals plenty of time to become familiar with the changes. Additionally, if necessary, guidelines and coding advice will be updated.
So, what is in store for April 1, 2022? There are three new ICD-10-CM codes being released all related to the vaccination status of patients, two of which are specific to COVID-19 vaccination status. Coding professionals will now be able to document if the patient is unvaccinated for COVID-19 (Z28.310), partially vaccinated for COVID-19 (Z28.311), or if there is other underimmunization status.
|
Description |
CC
|
MDC |
MS-DRG |
Z28.310
|
Unvaccinated for COVID-19 |
NonCC
|
23 |
951 |
Z28.311 |
Partially vaccinated for COVID-19 |
|
|
951 |
|
Other underimmunization status |
|
23 |
951 |
There are going to be seven new codes added to
ICD-10-PCS which address vaccination for COVID-19 and infusion of fostamatinib
to treat COVID-19.
Procedure Code
|
Description |
|
MDC |
MS-DRG |
XW013V7 |
Introduction of COVID-19 vaccine dose 3 into subcutaneous tissue, percutaneous approach, new technology group 7 |
N |
||
XW013W7
|
Introduction of COVID-19 vaccine booster into subcutaneous tissue, percutaneous approach, new technology group 7 |
N |
||
XW023V7
|
Introduction of COVID-19 vaccine dose 3 into muscle, percutaneous approach, new technology group 7 |
N |
||
XW023W7 |
Introduction of COVID-19 vaccine booster into muscle, percutaneous approach, new technology group 7 |
N |
||
XW0DXR7
|
Introduction of fostamatinib into mouth and pharynx, external approach, new technology group 7 |
N |
||
XW0G7R7 |
Introduction of fostamatinib into upper GI, via natural or artificial opening, new technology group 7 |
N |
||
XW0H7R7
|
Introduction of fostamatinib into lower GI, via natural or artificial opening, new technology group 7 |
N |
*As the procedure codes are designated as non-O.R. procedures, there is no assigned MDC or MS-DRG. The ICD-10MS-DRG assignment is dependent on the reported principal diagnosis, any secondary diagnoses defined as a complication or comorbidity (CC) or major complication or comorbidity (MCC), procedures or services performed, age, sex, and discharge status.
Certainly, much smaller update than coding
professionals are used to seeing, but there is no denying the need to be able
to capture this information. Data that
can be gleaned from the use of these codes may finally be able to help us put
this pandemic behind us for good.
Now you are In the kNOW!!
Source for Tables:
https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/AcuteInpatientPPS/MS-DRG-Classifications-and-Software?utm_medium=email&_hsmi=184119097&_hsenc=p2ANqtz-9sGVcmLV_yv960e8rCVbE-ESJDKFppvx6nf44Piksu0HEeeStbcHvobhA46Tm73UoSZiwhRz2iAyLNqS6-5bOrBIFGzQ&utm_content=184119097&utm_source=hs_email
About the Author
She recently served as the program director for Medical Coding and HIT at Eastern Gateway Community College. Dianna earned her bachelor's degree from the University of Cincinnati subsequently achieving her RHIA, CHPS, and CCS certifications. She is an AHIMA Approved ICD-10-CM/PCS Trainer and a a presenter at regional HIM meetings and the OHIMA Annual Meeting.